Next Article in Journal
Evolving Paradigms in Acute Myeloid Leukemia: Personalized Approaches to Therapy Across Age and Risk Groups
Previous Article in Journal
Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre Study
Previous Article in Special Issue
Risk Stratification of Thyroid Nodules Using Ultrasound Cine-Loop Video Sequences
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Impact of Ultrasonographic Features Indicative of Malignancy on Tumor Advancement in Thyroid Cancer—A Single-Center Study

1
Department of General Surgery, University Centre of General and Oncological Surgery, Faculty of Medicine, Wroclaw Medical University, 50-556 Wrocław, Poland
2
Doctoral School, Wroclaw Medical University, 50-345 Wrocław, Poland
3
Division of Medical Biology, Faculty of Nursing and Midwifery, Wroclaw Medical University, 50-368 Wrocław, Poland
4
Department of Endocrine Surgery, University Centre of General and Oncological Surgery, Faculty of Medicine, Wroclaw Medical University, 50-556 Wrocław, Poland
*
Authors to whom correspondence should be addressed.
Cancers 2025, 17(17), 2822; https://doi.org/10.3390/cancers17172822
Submission received: 20 July 2025 / Revised: 27 August 2025 / Accepted: 27 August 2025 / Published: 28 August 2025
(This article belongs to the Special Issue Thyroid Cancer: Diagnosis, Prognosis and Treatment (2nd Edition))

Simple Summary

This study of 724 patients between 2008 and 2024 with confirmed thyroid cancer (TC), comparing their ultrasound findings with surgical histopathology.

Abstract

Background: Ultrasonography is frequently used preoperatively to assess thyroid nodules. Hypoechogenicity, microcalcifications, high vascularity, or irregular tumor shape suggest malignancy. Methods: This is a retrospective analysis of 724 patients from 2008 to 2024 who underwent surgery for TC. Preoperative data, ultrasonographic findings, and histopathological results were collected. Ultrasonographic features indicative of possible malignancy included hypoechogenicity, microcalcifications, high vascularity, and irregular tumor shape. These were correlated with histopathologically seen extrathyroidal extension, capsular and vascular invasion, and lymph node metastasis. Results: A statistically significant association was seen for each of the evaluated ultrasonographic features (p < 0.05). More advanced TC had a greater number of suspicious ultrasonographic features averaging 3.05 to 3.12. Microcalcifications, high vascularity, and irregular tumor shape showed a strong correlation (r > 0.7) with all histopathological features. Hypoechogenicity had a strong correlation with lymph node metastasis and a moderate correlation (r = 0.5–0.7) with other features. Conclusions: Ultrasonographic features predict the likelihood of histopathological extrathyroidal extension, capsular and vascular invasion, and lymph node metastasis.

1. Introduction

Ultrasonography is a common imaging modality in thyroid cancer (TC). Nodule characteristics (hypoechogenicity, microcalcifications, high vascularity, irregular margins, size > 1 cm) and lymphadenopathy suggest malignancy [1]. Ultrasonographic findings are classified using Thyroid Imaging Reporting and Data System (TIRADS), most commonly in ACR-TIRADS and EU-TIRADS versions. Shear wave elastography is also sometimes used, with high sensitivity and specificity [2,3]. Cytology, via a fine-needle aspiration biopsy (FNAB), is evaluated using the Bethesda System for Reporting Thyroid Cytopathology (2023) [4,5].
This study of TC reports the correlation of ultrasonographic features with histopathological features.

2. Materials and Methods

This retrospective study included 724 patients from 2008 to 2024 who underwent surgery for TC. Preoperative data, ultrasonographic findings, and histopathological results were collected. Ultrasonographic features indicative of possible malignancy included hypoechogenicity, microcalcifications, high vascularity, and irregular tumor shape. Histopathological features indicative of TC advancement included extrathyroidal extension, capsular and vascular invasion, and lymph node metastasis (N+). The impact of ultrasonographic features on the presence of aggressive tumor characteristics was analyzed.

2.1. Statistical Analysis

Qualitative data were expressed as counts and percentages, while quantitative data were presented as medians with interquartile ranges, reflecting the non-normal distribution. The Shapiro–Wilk test was employed to evaluate the normality of quantitative variables. Group differences were examined using the Mann–Whitney U test for continuous variables, and the chi-square test was applied to compare categorical variables. Relationships between variables were analyzed using Spearman’s rank correlation, appropriate for non-parametric data. All statistical analyses were conducted using Statistica version 10.0 (StatSoft Inc., Tulsa, OK, USA). A p-value < 0.05 amounted to a statistically significant difference between the variables.

2.2. Study Group Overview

The study group is shown in Table 1. A total of 97% were Bethesda V–VI, and 195 required a second surgery. All patients had thyroid ultrasound and FNAB under ultrasound guidance. Some pN and pM are not known as routine prophylactic lymphadenectomy was not performed.

3. Results

3.1. Distribution of Ultrasonographic and Histopathological Features

The ultrasonographic features indicative of malignancy in TC include hypoechogenicity, microcalcifications, high vascularity in the center of the nodule, and irregular tumor shape (or margins). The majority of records (81%) had hypoechogenic lesions. Microcalcifications, high vascularity, and irregular shapes were observed in ~45%. The histopathological features we evaluated included extrathyroidal extension, capsular invasion, vascular invasion (each ~38%), and N+ (28%). The data are summarized in Figure 1.

3.2. Association Between Ultrasonographic and Histopathological Features

There was a statistically significant (p-value < 0.05 for all) relationship between the suspicious ultrasound features and the more concerning histopathological features. The results are presented in Table 2.

3.3. Impact of the Average Number of Ultrasonographic Features

An analysis of the number of suspicious ultrasound features showed that patients with malignant characteristics presented, on average, a higher number of studied ultrasonographic features. The average number of suspicious ultrasonography features in patients with concerning histopathological features was 3.05–3.12, compared with 2.70–2.88 of those without. The data are presented in Table 3.

3.4. Cross-Correlation Analysis

There is a strong correlation of suspicious ultrasonographic features with concerning histology (Figure 2). For hypoechogenicity, a strong correlation was seen with N+, and a moderate correlation was seen with extrathyroidal extension, capsular invasion, and vascular invasion. For microcalcifications, high vascularity, and irregular tumor shape, strong correlations were observed with all the histopathological features. An increase in the number of suspicious ultrasonographic features significantly elevates the likelihood of malignant characteristics.

4. Discussion

This study confirms that ultrasonographic features of thyroid nodules (microcalcifications, high vascularity, irregular lesion shape, and nodule hypoechogenicity) correlate with histopathological features (such as extrathyroidal extension, vascular invasion, thyroid capsular invasion, and lymph node metastases).
Hypoechogenic nodules were present in ~81% of TCs, like other series (71–99%) [6,7,8,9,10]. We observed moderate positive correlations between hypoechogenicity and extrathyroidal extension, capsular invasion, and vascular invasion (r = 0.68–0.7), similar to reports of 42% capsular invasion and 78% vascular invasion in hypoechoic nodules [11,12]. A strong correlation between hypoechogenicity and N+ central compartment (r = 0.71) has also been highlighted in the literature [13,14]. Microcalcifications were observed in 45% of TC cases, consistent with literature reports ranging from 34% to 59% [15,16,17]. This feature is highly specific but moderately sensitive. In some rare cases, TCs have been reported without a distinct nodule, with microcalcifications being the sole abnormality on ultrasound [18,19].
We observed strong correlations between microcalcifications and all histopathological features analyzed (r = 0.72–0.75). Literature reports vary, linking microcalcifications to selected histopathological features, perineural invasion, elevated vascular endothelial growth factor (VEGF) levels, or increased risk when present in more than five foci [20,21,22]. For lymph node metastases, rates of microcalcifications are 27–36%, usually in combination with other unfavorable ultrasonographic features [23,24,25,26].
Ultrasonographic TC features suggestive of malignancy should not be evaluated in isolation [13,14,23,24,25,26,27,28]. Our results are in line with the hypothesis that no single ultrasound feature reliably distinguishes benign from malignant thyroid lesions. Many studies note coexistent features [6,8,9,10,11,12,13,14,15,20,21,22,23,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40]. Patterns of high vascularity, particularly increased central nodule vascularity, were observed in 46% of cases in our study. The literature reports 17% to 92%, with a meta-analysis reporting ~50%, with the variability deriving, in part, from different criteria [29,30,41]. We also observed a similar proportion for irregular tumor shapes (46%), the same as in a literature review (47%). This parameter has been described as highly linked with TC, with specificity ranging from 83% to 97% [31,32,33,42]. In our study, both high vascularity and irregular tumor shape showed strong correlations with aggressive histological features of TC, including extrathyroidal extension (r = 0.74–0.76), capsular and vascular invasion (r = 0.76–0.79), and lymph node metastases (r = 0.75–0.77). Similar associations have been reported elsewhere, with vascularity being a key marker [27,28,34,35,43,44,45]. We saw the strongest correlation between vascularity and vascular invasion. Reported rates of lymph node metastases reach 70%, with an overall malignancy risk of up to 86% in thyroid nodules presenting high vascularity or irregular shape [27,28].
The average number of ultrasonographic features was significantly higher in TCs with unfavorable histopathological characteristics (3.05–3.12) compared to those without (2.70–2.88; p < 0.05). A cutoff of ≥3 suspicious features increased the likelihood of adverse pathology. Several studies have shown that the cumulative number strongly correlated with the likelihood of malignancy. It has been reported that ≥2 features markedly increase risk (specifically 89–97%), while another study reported malignancy rates of 48% with ≥3 features, compared to 5% with a single feature. EU-TIRADS category 5 also defines high-risk nodules in this regard, with malignancy risk rising as more of the suspicious patterns are present [36,37,38,46].

5. Conclusions

Our findings corroborate the literature regarding ultrasonographic features in thyroid imaging. An irregular appearance, alongside features such as hypoechogenicity, microcalcifications, and high vascularity, correlates with more unfavorable histopathological outcomes. Three positive ultrasonographic features correlate with a higher likelihood of unfavorable histopathology.

Author Contributions

Conceptualization, M.M.; methodology, M.M. and K.J.; software, K.J. and D.D.; validation, M.M.; formal analysis, M.M., K.J., B.W., D.D. and K.K.; investigation, M.M., K.J., N.K., M.R., S.B. and B.W.; resources, M.M., K.J., N.K., M.R., S.B., B.W. and K.K.; data curation, M.M., K.J., N.K., M.R., S.B., B.W. and D.D.; writing—original draft preparation, M.M.; writing—review and editing, M.M. and K.K.; visualization, M.M.; supervision, K.K.; project administration, M.M. and K.K.; funding acquisition, K.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Wroclaw Medical University via the Internal Grant for Science Development (grant number: SUBZ.A530.25.028).

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Bioethics Committee of the Wroclaw Medical University, Poland. Approval No. KB-241/2023; 24 February 2023.

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study. This research was approved by the appropriate Bioethics Committee. The data were analyzed retrospectively and anonymously from medical records. The authors did not have direct contact with the study participants.

Data Availability Statement

The datasets used and/or analyzed during this research are available from the corresponding author upon reasonable request.

Acknowledgments

The authors are grateful to all the patients and medical staff at the study center who contributed to this research.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Remonti, L.R.; Kramer, C.K.; Leitão, C.B.; Pinto, L.C.; Gross, J.L. Thyroid ultrasound features and risk of carcinoma: A systematic review and meta-analysis of observational studies. Thyroid 2015, 25, 538–550. [Google Scholar] [CrossRef]
  2. Liang, F.; Li, X.; Ji, Q.; He, D.; Yang, M.; Xu, Z. Revised Thyroid Imaging Reporting and Data System (TIRADS): Imitating the American College of Radiology TIRADS, a single-center retrospective study. Quant. Imaging Med. Surg. 2023, 13, 3862–3872. [Google Scholar] [CrossRef] [PubMed]
  3. Zhang, B.; Ma, X.; Wu, N.; Liu, L.; Liu, X.; Zhang, J.; Yang, J.; Niu, T. Shear wave elastography for differentiation of benign and malignant thyroid nodules: A meta-analysis. J. Ultrasound Med. 2013, 32, 2163–2169. [Google Scholar] [CrossRef] [PubMed]
  4. Ali, S.Z.; Baloch, Z.W.; Cochand-Priollet, B.; Schmitt, F.C.; Vielh, P.; VanderLaan, P.A. The 2023 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2023, 33, 1039–1044. [Google Scholar] [CrossRef]
  5. Baloch, Z.W.; Asa, S.L.; Barletta, J.A.; Ghossein, R.A.; Juhlin, C.C.; Jung, C.K.; LiVolsi, V.A.; Papotti, M.G.; Sobrinho-Simões, M.; Tallini, G.; et al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr. Pathol. 2022, 33, 27–63. [Google Scholar] [CrossRef] [PubMed]
  6. Wu, M.H.; Chen, C.N.; Chen, K.Y.; Ho, M.C.; Tai, H.C.; Wang, Y.H.; Chen, A.; Chang, K.J. Quantitative analysis of echogenicity for patients with thyroid nodules. Sci. Rep. 2016, 6, 35632. [Google Scholar] [CrossRef]
  7. Lee, J.Y.; Lee, C.Y.; Hwang, I.; You, S.H.; Park, S.W.; Lee, B.; Yoon, R.G.; Yim, Y.; Kim, J.H.; Na, D.G. Malignancy risk stratification of thyroid nodules according to echotexture and degree of hypoechogenicity: A retrospective multicenter validation study. Sci. Rep. 2022, 12, 16587. [Google Scholar] [CrossRef] [PubMed]
  8. Popova, N.M.; Radzina, M.; Prieditis, P.; Liepa, M.; Rauda, M.; Stepanovs, K. Impact of the Hypoechogenicity Criteria on Thyroid Nodule Malignancy Risk Stratification Performance by Different TIRADS Systems. Cancers 2021, 13, 5581. [Google Scholar] [CrossRef]
  9. Hahn, S.Y.; Han, B.K.; Ko, E.Y.; Shin, J.H.; Ko, E.S. Ultrasound findings of papillary thyroid carcinoma originating in the isthmus: Comparison with lobe-originating papillary thyroid carcinoma. AJR Am. J. Roentgenol. 2014, 203, 637–642. [Google Scholar] [CrossRef]
  10. Jiao, W.P.; Zhang, L. Using Ultrasonography to Evaluate the Relationship Between Capsular Invasion or Extracapsular Extension and Lymph Node Metastasis in Papillary Thyroid Carcinomas. Chin. Med. J. 2017, 130, 1309–1313. [Google Scholar] [CrossRef]
  11. Lai, X.; Zhang, B.; Jiang, Y.; Li, J.; Zhao, R.; Yang, X.; Zhang, X.; Zhu, S.; Wu, Q.; Cai, S.; et al. Sonographic and Clinical Features of Papillary Thyroid Microcarcinoma Less than or Equal to Five Millimeters: A Retrospective Study. PLoS ONE 2016, 11, e0148567. [Google Scholar] [CrossRef]
  12. Kaliszewski, K.; Diakowska, D.; Rzeszutko, M.; Nowak, Ł.; Aporowicz, M.; Wojtczak, B.; Sutkowski, K.; Rudnicki, J. Risk factors of papillary thyroid microcarcinoma that predispose patients to local recurrence. PLoS ONE 2020, 15, e0244930. [Google Scholar] [CrossRef] [PubMed]
  13. Lee, Y.S.; Lim, Y.S.; Lee, J.C.; Wang, S.G.; Son, S.M.; Kim, S.S.; Kim, I.J.; Lee, B.J. Ultrasonographic findings relating to lymph node metastasis in single micropapillary thyroid cancer. World J. Surg. Oncol. 2014, 12, 273. [Google Scholar] [CrossRef]
  14. Wang, X.Q.; Wei, W.; Wei, X.; Xu, Y.; Wang, H.L.; Xing, X.J.; Zhang, S. Study on the relationship between ultrasonographic features of papillary thyroid carcinoma and central cervical lymph node metastasis. Zhonghua Zhong Liu Za Zhi 2018, 40, 196–200. (In Chinese) [Google Scholar] [CrossRef] [PubMed]
  15. Smith-Bindman, R.; Lebda, P.; Feldstein, V.A.; Sellami, D.; Goldstein, R.B.; Brasic, N.; Jin, C.; Kornak, J. Risk of thyroid cancer based on thyroid ultrasound imaging characteristics: Results of a population-based study. JAMA Intern. Med. 2013, 173, 1788–1796. [Google Scholar] [CrossRef] [PubMed]
  16. Ha, J.; Lee, J.; Jo, K.; Han, J.S.; Kim, M.H.; Jung, C.K.; Kang, M.I.; Cha, B.Y.; Lim, D.J. Calcification Patterns in Papillary Thyroid Carcinoma are Associated with Changes in Thyroid Hormones and Coronary Artery Calcification. J. Clin. Med. 2018, 7, 183. [Google Scholar] [CrossRef]
  17. Lu, Z.; Mu, Y.; Zhu, H.; Luo, Y.; Kong, Q.; Dou, J.; Lu, J. Clinical value of using ultrasound to assess calcification patterns in thyroid nodules. World J. Surg. 2011, 35, 122–127. [Google Scholar] [CrossRef]
  18. Kwak, J.Y.; Kim, E.K.; Son, E.J.; Kim, M.J.; Oh, K.K.; Kim, J.Y.; Kim, K.I. Papillary thyroid carcinoma manifested solely as microcalcifications on sonography. AJR Am. J. Roentgenol. 2007, 189, 227–231. [Google Scholar] [CrossRef]
  19. Ioakim, S.; Constantinides, V.; Toumba, M.; Lyssiotis, T.; Kyriacou, A. Microcalcifications without a thyroid nodule as the sole sign of papillary thyroid carcinoma. Endocrinol. Diabetes Metab. Case Rep. 2021, 2021, 21-0072. [Google Scholar] [CrossRef]
  20. Hekimsoy, İ.; Ertan, Y.; Serin, G.; Karabulut, A.K.; Özbek, S.S. Comparison of ultrasound findings of papillary thyroid carcinoma subtypes based on the 2022 WHO classification of thyroid neoplasms. Front. Endocrinol. 2024, 15, 1434787. [Google Scholar] [CrossRef]
  21. Li, J.; Shi, M.; Sun, X.; Zhang, B.; Cao, Y.; Su, J.; Chen, Z. Correlation between ultrasound characteristics of thyroid microcarcinoma and levels of thyroid-stimulating hormone and vascular endothelial growth factor. Am. J. Transl. Res. 2025, 17, 1938–1949. [Google Scholar] [CrossRef]
  22. Nabahati, M.; Mehraeen, R.; Moazezi, Z.; Ghaemian, N. Can sonographic features of microcalcification predict thyroid nodule malignancy? a prospective observational study. Egypt. J. Radiol. Nucl. Med. 2021, 52, 117. [Google Scholar] [CrossRef]
  23. Song, W.J.; Um, I.C.; Kwon, S.R.; Lee, J.H.; Lim, H.W.; Jeong, Y.U.; Chung, S.M.; Moon, J.S.; Yoon, J.S.; Won, K.C.; et al. Predictive factors of lymph node metastasis in papillary thyroid cancer. PLoS ONE 2023, 18, e0294594. [Google Scholar] [CrossRef] [PubMed]
  24. Oh, E.M.; Chung, Y.S.; Song, W.J.; Lee, Y.D. The pattern and significance of the calcifications of papillary thyroid microcarcinoma presented in preoperative neck ultrasonography. Ann. Surg. Treat. Res. 2014, 86, 115–121. [Google Scholar] [CrossRef] [PubMed]
  25. Kuma, K.; Matsuzuka, F.; Kobayashi, A.; Hirai, K.; Morita, S.; Miyauchi, A.; Katayama, S.; Sugawara, M. Outcome of long standing solitary thyroid nodules. World J. Surg. 1992, 16, 583–588. [Google Scholar] [CrossRef]
  26. Liu, Y.I.; Kamaya, A.; Desser, T.S.; Rubin, D.L. A Bayesian classifier for differentiating benign versus malignant thyroid nodules using sonographic features. AMIA Annu. Symp. Proc. 2008, 2008, 419–423. [Google Scholar]
  27. Chung, S.R.; Baek, J.H.; Rho, Y.H.; Choi, Y.J.; Sung, T.Y.; Song, D.E.; Kim, T.Y.; Lee, J.H. Sonographic Diagnosis of Cervical Lymph Node Metastasis in Patients with Thyroid Cancer and Comparison of European and Korean Guidelines for Stratifying the Risk of Malignant Lymph Node. Korean J. Radiol. 2022, 23, 1102–1111. [Google Scholar] [CrossRef]
  28. Li, F.; Pan, D.; He, Y.; Wu, Y.; Peng, J.; Li, J.; Wang, Y.; Yang, H.; Chen, J. Using ultrasound features and radiomics analysis to predict lymph node metastasis in patients with thyroid cancer. BMC Surg. 2020, 20, 315. [Google Scholar] [CrossRef]
  29. Shin, J.H.; Baek, J.H.; Chung, J.; Ha, E.J.; Kim, J.H.; Lee, Y.H.; Lim, H.K.; Moon, W.J.; Na, D.G.; Park, J.S.; et al. Ultrasonography Diagnosis and Imaging-Based Management of Thyroid Nodules: Revised Korean Society of Thyroid Radiology Consensus Statement and Recommendations. Korean J. Radiol. 2016, 17, 370–395. [Google Scholar] [CrossRef]
  30. Khadra, H.; Bakeer, M.; Hauch, A.; Hu, T.; Kandil, E. Is vascular flow a predictor of malignant thyroid nodules? A meta-analysis. Gland Surg. 2016, 5, 576–582. [Google Scholar] [CrossRef]
  31. Rahemi Karizaki, S.; Alamdaran, S.A.; Bonakdaran, S.; Morovatdar, N.; Jafarain, A.H.; Sharifi Hadad, A.; Hadadzade, A. New Proposed Formula of Ti-Rads Classification Based on Ultrasound Findings. Acta Endocrinol. 2020, 6, 199–207. [Google Scholar] [CrossRef]
  32. Zhao, R.N.; Zhang, B.; Jiang, Y.X.; Yang, X.; Lai, X.J.; Zhu, S.L.; Zhang, X.Y. Ultrasonographic Multimodality Diagnostic Model of Thyroid Nodules. Ultrason. Imaging 2019, 41, 63–77. [Google Scholar] [CrossRef]
  33. Brito, J.P.; Gionfriddo, M.R.; Al Nofal, A.; Boehmer, K.R.; Leppin, A.L.; Reading, C.; Callstrom, M.; Elraiyah, T.A.; Prokop, L.J.; Stan, M.N.; et al. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: Systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2014, 99, 1253–1263. [Google Scholar] [CrossRef] [PubMed]
  34. Lin, M.; Su, Y.; Huang, Y.; Zhang, H.; Zeng, J.; Zhuang, Y.; Ye, X.; Chen, S. Ultrasonographic evaluation of extracapsular vascular invasion for subcapsular nodules of the thyroid. Transl. Cancer Res. 2020, 9, 6464–6470. [Google Scholar] [CrossRef] [PubMed]
  35. Leong, D.; Ng, K.; Nguyen, H.; Ryan, S. Preoperative ultrasound characteristics in determining the likelihood of requiring completion thyroidectomy for cytologically confirmed (Bethesda VI) papillary thyroid tumors with 1–4 cm in diameter. Asian J. Surg. 2022, 45, 197–201. [Google Scholar] [CrossRef]
  36. Peccin, S.; de Castsro, J.A.; Furlanetto, T.W.; Furtado, A.P.; Brasil, B.A.; Czepielewski, M.A. Ultrasonography: Is it useful in the diagnosis of cancer in thyroid nodules? J. Endocrinol. Investig. 2002, 25, 39–43. [Google Scholar] [CrossRef] [PubMed]
  37. Grani, G.; Del Gatto, V.; Cantisani, V.; Mandel, S.J.; Durante, C. A Reappraisal of Suspicious Sonographic Features of Thyroid Nodules: Shape Is Not an Independent Predictor of Malignancy. J. Clin. Endocrinol. Metab. 2023, 108, e816–e822. [Google Scholar] [CrossRef]
  38. Liang, L.; Xie, J.; Li, S.; Yang, J.; Chen, D.; Wang, N.; Zhou, Z. Nomogram for the diagnosis of suspected papillary thyroid carcinomas based on sonographic patterns: A retrospective study. Gland Surg. 2019, 8, 362–369. [Google Scholar] [CrossRef]
  39. Şah Ünal, F.T.; Gökçay Canpolat, A.; Elhan, A.H.; Sevim, S.; Sak, S.D.; Emral, R.; Demir, Ö.; Güllü, S.; Erdoğan, M.F.; Çorapçıoğlu, D.; et al. Cancer rates and characteristics of thyroid nodules with macrocalcification. Endocrine 2024, 84, 1021–1029. [Google Scholar] [CrossRef]
  40. Lei, R.; Wang, Z.; Qian, L. Ultrasonic Characteristics of Medullary Thyroid Carcinoma: Differential from Papillary Thyroid Carcinoma and Benign Thyroid Nodule. Ultrasound Q. 2021, 37, 329–335. [Google Scholar] [CrossRef]
  41. Sultan, L.R.; Xiong, H.; Zafar, H.M.; Schultz, S.M.; Langer, J.E.; Sehgal, C.M. Vascularity assessment of thyroid nodules by quantitative color Doppler ultrasound. Ultrasound Med. Biol. 2015, 41, 1287–1293. [Google Scholar] [CrossRef]
  42. Bojunga, J.; Herrmann, E.; Meyer, G.; Weber, S.; Zeuzem, S.; Friedrich-Rust, M. Real-time elastography for the differentiation of benign and malignant thyroid nodules: A meta-analysis. Thyroid 2010, 20, 1145–1150. [Google Scholar] [CrossRef]
  43. Wan, F.; He, W.; Zhang, W.; Zhang, Y.; Zhang, H.; Guang, Y. Preoperative prediction of extrathyroidal extension: Radiomics signature based on multimodal ultrasound to papillary thyroid carcinoma. BMC Med. Imaging 2023, 23, 96. [Google Scholar] [CrossRef] [PubMed]
  44. Miciak, M.; Jurkiewicz, K.; Dziekiewicz, A.; Biernat, S.; Kisiel, M.; Wojtczak, B.; Diakowska, D.; Kaliszewski, K. Influence of Tumor Laterality and Focality on Clinical Implications and Tumor Advancement in Well-Differentiated Thyroid Cancer. Cancers 2024, 16, 4109. [Google Scholar] [CrossRef] [PubMed]
  45. Yamazaki, H.; Katoh, R.; Sugino, K.; Matsuzu, K.; Masaki, C.; Akaishi, J.; Hames, K.Y.; Tomoda, C.; Suzuki, A.; Ohkuwa, K.; et al. Correction: Encapsulated Angioinvasive Follicular Thyroid Carcinoma: Prognostic Impact of the Extent of Vascular Invasion. Ann. Surg. Oncol. 2022, 29, 8213. [Google Scholar] [CrossRef] [PubMed]
  46. Russ, G.; Bonnema, S.J.; Erdogan, M.F.; Durante, C.; Ngu, R.; Leenhardt, L. European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS. Eur. Thyroid J. 2017, 6, 225–237. [Google Scholar] [CrossRef]
Figure 1. Overview of ultrasonographic and histopathological TC features across the study group.
Figure 1. Overview of ultrasonographic and histopathological TC features across the study group.
Cancers 17 02822 g001aCancers 17 02822 g001b
Figure 2. Correlations between ultrasound and histopathology determined using Spearman’s correlation test (r). Note: correlations between variables: 0–0.5, weak; 0.5–0.7, moderate; >0.7, strong.
Figure 2. Correlations between ultrasound and histopathology determined using Spearman’s correlation test (r). Note: correlations between variables: 0–0.5, weak; 0.5–0.7, moderate; >0.7, strong.
Cancers 17 02822 g002
Table 1. Study group (n = 724) demographics—clinical and pathological characteristics.
Table 1. Study group (n = 724) demographics—clinical and pathological characteristics.
FeatureQuantity (Percentage)
SexM:F110 (15%): 614 (85%)
Age<55 years404 (56%)
≥55 years320 (44%)
Type of thyroidectomyTotal516 (71%)
Hemi (Lobectomy)208 (29%)
Reoperation procedureYes195 (27%)
No529 (73%)
FNAB ResultMalignant or suspicious (Bethesda V/VI)705 (97%)
Indeterminate (Bethesda III/IV)15 (2%)
Benign (Bethesda II)4 (1%)
Histological type of TCPapillary TC629 (87%)
Follicular TC36 (5%)
Medullary TC26 (4%)
Anaplastic TC17 (2%)
Lymphoma5 (<1%)
Secondary lesion4 (<1%)
Squamous cell tumor3 (<1%)
Sarcoma3 (<1%)
Myeloma1 (<1%)
TNM stageI539 (74%)
II112 (16%)
III36 (5%)
IV37 (5%)
pT stagepT1a292 (40%)
pT1b287 (40%)
pT285 (12%)
pT326 (3%)
pT4a12 (2%)
pT4b22 (3%)
pN stagepN0485 (67%)
pN1a184 (25%)
pN1b19 (3%)
pNx36 (5%)
pM stagepM0582 (80%)
pM139 (5%)
pMx103 (15%)
Table 2. Chi-square test analyses of the association between ultrasonographic and histopathological TC features. A p-value of <0.05 represents a statistically significant difference.
Table 2. Chi-square test analyses of the association between ultrasonographic and histopathological TC features. A p-value of <0.05 represents a statistically significant difference.
Extrathyroidal
Extension
Capsular
Invasion
Vascular
Invasion
Lymph Node
Metastases
Hypoechogenicityp < 0.05p < 0.05p < 0.05p < 0.05
Microcalcificationsp < 0.05p < 0.05p < 0.05p < 0.05
High Vascularityp < 0.05p < 0.05p < 0.05p < 0.05
Irregular Tumor Shapep < 0.05p < 0.05p < 0.05p < 0.05
Table 3. Mann–Whitney U test analyses of average number of ultrasonographic TC features. A p-value of <0.05 represents a statistically significant difference.
Table 3. Mann–Whitney U test analyses of average number of ultrasonographic TC features. A p-value of <0.05 represents a statistically significant difference.
Histopathological
Feature
Average Number of
Ultrasonographic Features
(Positive Result
of Histopathology)
Average Number of
Ultrasonographic Features (Negative Result
of Histopathology)
p-Value
Extrathyroidal Extension3.122.78<0.05
Capsular Invasion3.052.72<0.05
Vascular Invasion3.062.70<0.05
Lymph Node Metastases3.082.88<0.05
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Miciak, M.; Jurkiewicz, K.; Kalka, N.; Reiner, M.; Biernat, S.; Diakowska, D.; Wojtczak, B.; Kaliszewski, K. Impact of Ultrasonographic Features Indicative of Malignancy on Tumor Advancement in Thyroid Cancer—A Single-Center Study. Cancers 2025, 17, 2822. https://doi.org/10.3390/cancers17172822

AMA Style

Miciak M, Jurkiewicz K, Kalka N, Reiner M, Biernat S, Diakowska D, Wojtczak B, Kaliszewski K. Impact of Ultrasonographic Features Indicative of Malignancy on Tumor Advancement in Thyroid Cancer—A Single-Center Study. Cancers. 2025; 17(17):2822. https://doi.org/10.3390/cancers17172822

Chicago/Turabian Style

Miciak, Michał, Krzysztof Jurkiewicz, Natalia Kalka, Maja Reiner, Szymon Biernat, Dorota Diakowska, Beata Wojtczak, and Krzysztof Kaliszewski. 2025. "Impact of Ultrasonographic Features Indicative of Malignancy on Tumor Advancement in Thyroid Cancer—A Single-Center Study" Cancers 17, no. 17: 2822. https://doi.org/10.3390/cancers17172822

APA Style

Miciak, M., Jurkiewicz, K., Kalka, N., Reiner, M., Biernat, S., Diakowska, D., Wojtczak, B., & Kaliszewski, K. (2025). Impact of Ultrasonographic Features Indicative of Malignancy on Tumor Advancement in Thyroid Cancer—A Single-Center Study. Cancers, 17(17), 2822. https://doi.org/10.3390/cancers17172822

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop